erythromycin has been researched along with em703 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudoh, S; Li, YJ; Matsuda, K; Omura, S; Shimizu, T; Sunazuka, T; Takahashi, S; Usuki, J | 1 |
| Gouda, H; Hirono, S; Omura, S; Sakoh, Y; Sugawara, A; Sunazuka, T; Yoshida, K | 1 |
| Hamasaki, Y; Hatamochi, A; Ikeda, H; Omura, S; Sunazuka, T; Suzuki, H; Yamazaki, S | 1 |
| Abe, S; Azuma, A; Kudoh, S; Li, Y; Matsuda, K; Omura, S; Sunazuka, T; Usuki, J; Wang, C; Yu, C | 1 |
| Akagawa, KS; Iwamoto, A; Komuro, I; Omura, S; Sunazuka, T; Yokota, Y | 1 |
| Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudo, S; Omura, S; Ri, E; Shimizuq, T; Sugawara, I; Sunazuka, T; Takizawa, H | 1 |
| Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudoh, S; Li, YJ; Omura, S; Shimizu, T; Sugawara, I; Sunazuka, T; Takizawa, H | 1 |
7 other study(ies) available for erythromycin and em703
| Article | Year |
|---|---|
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Topics: Animals; Anti-Inflammatory Agents; Base Sequence; Bleomycin; Cell Line; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Lung; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Pulmonary Fibrosis; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta | 2006 |
Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation.
Topics: Cell Differentiation; Drug Evaluation, Preclinical; Erythromycin; Humans; Hydrogen Bonding; Imaging, Three-Dimensional; In Vitro Techniques; Macrophages; Magnetic Resonance Spectroscopy; Models, Molecular; Monocytes; Solutions; Stereoisomerism; Structure-Activity Relationship | 2006 |
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
Topics: Adult; Anti-Bacterial Agents; CCAAT-Binding Factor; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Erythromycin; Female; Fibroblasts; Humans; Infant; Male; Middle Aged; Promoter Regions, Genetic; RNA, Messenger; Scleroderma, Systemic; Transcription, Genetic | 2008 |
EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts.
Topics: Anti-Bacterial Agents; Antifibrinolytic Agents; Cell Line; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Erythromycin; Fibroblasts; Gene Expression; Humans; Phosphorylation; RNA, Messenger; Smad Proteins; Transforming Growth Factor beta | 2008 |
Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta.
Topics: CCAAT-Enhancer-Binding Protein-beta; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Disease Susceptibility; Erythromycin; HIV-1; Humans; Macrophages; Mitogen-Activated Protein Kinases; Protein Isoforms; Proto-Oncogene Proteins c-hck; Virus Replication | 2008 |
[EM and EM703 suppress inflammatory cytokines formation by human respiratory epithelial cells provoked by diesel exhaust particles].
Topics: Cells, Cultured; Erythromycin; Heme Oxygenase (Decyclizing); Humans; In Vitro Techniques; Interleukin-8; Oxidative Stress; Respiratory Mucosa; Vehicle Emissions | 2009 |
EM, EM703 inhibit NF-kB activation induced by oxidative stress from diesel exhaust particle in human bronchial epithelial cells: importance in IL-8 transcription.
Topics: Anti-Inflammatory Agents; Cell Line; Cytokines; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Inflammation Mediators; Interleukin-8; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Particulate Matter; Vehicle Emissions | 2013 |